Stock reports › US › Technology
Oracle Corporation (ORCL) stock analysis
Oracle trades near $127 after a 46% one-year slide, with cheap forward earnings and heavy debt-funded AI spending
Oracle (ORCL) closed at 127.11 on Nov 12, 2026, down 46.17% over a year and 49.21% below its 52-week high, while revenue growth accelerated to 29.61% in the latest quarter. Forward P/E of 13.42 sits well below the industry median of 19.48, but free cash flow is negative at -28.72B and net debt is 118.85B. Analysts are split in recent weeks, with 4 upgrades and 5 downgrades in the past 30 days.
- Price: 115.06
- Market Cap (USD): $341.27B
- P/E: 18.04×
- Fwd P/E: 12.08×
- Div Yield: 1.74%
- 1Y Return: -48.37%
- Next Earnings: Dec 14, 2026
- Mean Target: 228.92
- Rating: Buy
Bull case
- Revenue grew 29.61% year over year in the latest quarter (Q1 FY2027, revenue 19.34B), and EPS growth of 54.46% was ahead of the 47.69% trailing-year pace.
- Forward P/E of 13.42 is in the 20th percentile of US Technology and below the sector median of 19.55, while consensus expects next-fiscal-year EPS growth of 36.31%.
- Analysts' mean target is 214.31 from 24 analysts with a Buy label, and the last earnings report on Sep 10, 2026 beat EPS consensus by 10.34% (the fourth straight beat).
Bear case
- Capex of -75.66B against operating cash flow of 46.94B left trailing free cash flow at -28.72B, a free cash flow yield of -7.62%, in the 2nd percentile of the sector.
- Total debt of 155.93B gives debt to equity of 2.34 (95th percentile) and net debt to EBITDA of 3.15, with interest coverage of 4.55 and an Altman Z-score of 1.47.
- The stock fell 7.02% after the Sep 10 report despite the beat, and is 17.64% below its 200-day average with a relative strength rating of 16 and a 1-year max drawdown of -53.66%.
What to watch
- Next earnings on Dec 14, 2026 (not yet confirmed); consensus EPS is 1.88.
- The 20-day high of 148.48 and the 20-day and 52-week low of 109.21 as near-term range boundaries.
- The 50-day average at 137.24 and the 200-day average at 154.33, both above the current price.
- Short interest data due after the Oct 30, 2026 reading of 46.4M shares (1.56% of float).
General
Oracle provides enterprise IT solutions, including cloud software-as-a-service applications such as Fusion Cloud and NetSuite. Growth is accelerating, and the shares are cheap on forward earnings, but the balance sheet is stretched by heavy spending and the stock has fallen sharply.
Business and momentum
Cloud was 33.99B, or 50.46%, of fiscal 2026 revenue of 67.36B, followed by software at 24.54B. Trailing revenue is 71.78B, and quarterly revenue has risen for 4 straight quarters, reaching 19.34B in the quarter ended Aug 31, 2026.
Valuation in context
Forward P/E is 13.42 against an industry median of 19.48, and the PEG is 0.37. Trailing P/E is 19.93, in the 24th percentile of US Technology. The dividend yield is 1.57% with a payout ratio of 31.35%.
Analysts and market signals
The consensus label is Buy, with 59 buy, 24 hold and 4 sell ratings. Early November saw mixed actions: UBS, Wells Fargo and Goldman Sachs downgraded, while Stephens and Compass Point upgraded. News flow on Nov 12 cited an AI cloud rebound cooling.
Main risks
Free cash flow is -28.72B and total debt is 155.93B. The stock has fallen 34.79% year to date and is highly volatile, with 1-year beta of 2.23 and 30-day realized volatility of 74.74%.
Long-term investor
Growth has stepped up from a 10.72% five-year revenue CAGR to 21.62% over the past year, and returns on equity are high. Durability is the question, since returns on invested capital are modest at 9.89% and the buildout is funded by debt with negative free cash flow.
Growth and margins
Annual revenue rose from 40.48B in fiscal 2021 to 67.36B in fiscal 2026, and EPS from 4.55 to 5.83. Operating margin is 32.36% (82nd percentile), up 1.92% over a year, while gross margin fell 5.72% over the same period to 63.95%.
Returns and balance sheet
ROE is 41.62%, but ROIC of 9.89% is below the sector median of 16.30%. Debt to equity of 2.34 and a Piotroski F-score of 4 point to limited balance sheet cushion, with cash of 37.08B against total debt of 155.93B.
Cash returned
Dividends paid were 5.79B in fiscal 2026, up from 4.74B, with 12 years of dividend growth. Buybacks fell to 206.0M from 1.50B, and shares outstanding rose 3.13% over a year, so dilution is a factor.
Estimates, insiders and ownership
Consensus EPS is 8.14 for this fiscal year and 11.09 for next year, with 30-day revisions flat at -0.00%. Insiders show 3 sells and 1 buy in 90 days, net -1.9M. Institutional ownership is 45.13%, up 2.75% over three months.
Swing trader
The trend is down, with price below the 50-day and 200-day averages and a death cross dated Jan 7, 2026. A sharp bounce off the 109.21 low has brought price back to the 20-day average, with weak trend strength and very large daily ranges.
Trend and momentum
Price of 127.11 is 0.29% above the 20-day average of 126.74, 7.38% below the 50-day at 137.24 and 17.64% below the 200-day at 154.33. RSI is 48.43, MACD of -4.02 is above its signal at -4.35, and ADX of 13.35 shows no firm trend.
Recent sessions and levels
Price hit 109.21 intraday on Nov 6, then closed at 128.38 on Nov 11 on 38.8M shares. Nov 12 closed lower at 127.11 on 22.4M, a relative volume of 0.59. Overhead sits 148.48, the Oct 28 high.
Volatility and relative strength
ATR is 8.20, or 6.45% of price, so stops need wide room. The relative strength rating is 16 and 6-month relative strength is -34.70%. Beta over one year is 2.23.
Catalysts and flow
Earnings fall on Dec 14, 2026, 32 days away. Last earnings produced a -7.02% move. Short interest is 1.56% of float and falling, so squeeze potential looks limited. Analyst actions were mixed in early November.
Options
Implied volatility is mid-range, with a 30-day level of 58.94% and an IV rank of 42, but it sits below realized volatility. Liquidity is strong, and the next earnings date falls after the standard 30-day expiry.
Implied level and term structure
30-day IV is 58.94% against a 52-week range of 39.60% to 85.35%, giving an IV rank of 42 and an IV percentile of 50. The term structure is in contango: 60-day IV is 64.40% and 90-day is 60.94%. 25-delta skew is -5.6 points.
Implied versus realized
The 30-day IV/HV ratio is 0.79 and the volatility risk premium is -19.4 points, with 30-day realized volatility at 74.74%. Option premium is therefore cheap relative to recent realized moves, which favors buyers over sellers on that measure.
Expected moves and earnings
The implied 30-day move is 16.90% (21.48), and the 7-day move is 8.16%. Earnings on Dec 14 fall outside the Dec 11 expiry. Past earnings moves averaged 8.86% over 4 quarters and 12.51% over 8, with a maximum of 37.68%.
Premium yield and liquidity
For the Dec 11 expiry, the 118.00 put (30-delta) pays 3.58, an annualized 38.19% cash-secured yield, and the 141.00 call pays 4.63, a 45.86% covered-call yield. The liquidity score is 100, with put/call volume at 0.52.
Analysis written November 12, 2026 from Qanvo data as of November 12, 2026. AI-generated, for information only; not investment advice.